Aperture Sectors › Healthcare & Life Sciences › Brain-computer interfaces & neurotech
Brain-computer interfaces & neurotech funding
Brain-computer interfaces & neurotech
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
56 rounds, $2.6B raised by 49 companies, Jan 2, 2023 to Nov 14, 2026, 6% of Healthcare & Life Sciences capital. Top three companies: Neuralink 38%, Precision Neuroscience 15%, Merge Labs 10%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| Neuralink | United States | $973M | 3 | — |
| Precision Neuroscience | United States | $393M | 3 | — |
| Merge Labs | United States | $252M | 1 | — |
| Synchron | United States | $200M | 1 | — |
| NeuroXess | China | $105M | 1 | — |
| Beacon Biosignals | United States | $97M | 1 | — |
| Gestala | China | $84M | 2 | — |
| CoMind | United Kingdom | $60M | 1 | — |
| Mindtrix (明视脑机) | China | $52M | 1 | — |
| INBRAIN Neuroelectronics | Spain | $50M | 1 | — |
| Active Technology (主动科技) | China | $49M | 2 | — |
| Neurable | United States | $35M | 1 | — |
| Zeto | United States | $31M | 1 | — |
| BCI-Sonics | China | $30M | 1 | — |
| Fasikl | United States | $26M | 1 | — |
| Epitel | United States | $26M | 1 | — |
| Esonitro (君柔科技) | China | $15M | 1 | — |
| Newronika | Italy | $14M | 1 | — |
| Elemind | United States | $12M | 1 | — |
| brain.space | Israel | $11M | 1 | — |
| Arctop | United States | $10M | 1 | — |
| 致远科创（四川）有限责任公司 | China | $5.2M | 1 | — |
| Samphire Neuroscience | United States | $5M | 1 | — |
| Cumulus Neuroscience | United Kingdom | $4.4M | 1 | — |
| Sychedelic | India | $3.5M | 1 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| Neuralink | $650M | Series E | May 27, 2025 |
| Neuralink | $280M | Series D | Aug 7, 2023 |
| Merge Labs | $252M | Seed | Jan 15, 2026 |
| Precision Neuroscience | $250M | Series D | Sep 24, 2026 |
| Synchron | $200M | Series D | Nov 6, 2025 |
| NeuroXess | $105M | Series B | Oct 28, 2026 |
| Precision Neuroscience | $102M | Series C | Dec 16, 2024 |
| Beacon Biosignals | $97M | Series B | Nov 13, 2025 |
| Gestala | $62M | Seed | Jul 3, 2026 |
| CoMind | $60M | Series A | Oct 20, 2025 |